Mezzion Pharma Co.Ltd (140410) — Cash Flow Quality Index

Latest as of March 2024: -20.29x

Mezzion Pharma Co.Ltd (140410) has a Cash Flow Quality Index of -20.29x as of March 2024. Operating cash flow of ₩-1.47 Billion is below net income of ₩72.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Mezzion Pharma Co.Ltd generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-20.29x
Operating CF / Net Income

Operating Cash Flow

₩-1.47 Billion
KRW

Net Income

₩72.59 Million
KRW

Data as of

Mar 2024
Most recent filing

Mezzion Pharma Co.Ltd Cash Flow Quality Index (2012–2015)

Historical Cash Flow Quality Index for Mezzion Pharma Co.Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Mezzion Pharma Co.Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Mezzion Pharma Co.Ltd (2012–2015)

Year-by-year earnings quality comparison for Mezzion Pharma Co.Ltd. For live market cap and the full company financial profile, see 140410 company net worth.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2015 0.34x ₩1.77 Billion ₩5.16 Billion ▼ -73.9%
2012 1.32x ₩3.14 Billion ₩2.38 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.